← Back to Search

Anti-epileptic drug

Gralise for Pain

Phase 3
Waitlist Available
Led By Kenneth D Candido, M.D.
Research Sponsored by Chicago Anesthesia Pain Specialists
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up visit 1, 2, 3, 4, 5, 6
Awards & highlights

Study Summary

Phantom limb pain (PLP) is a common disorder reported by the patients who undergo amputation. Even though the cause of PLP remains unclear, Gabapentin has been widely used. The purpose of this study is to evaluate the accuracy and efficacy achieved in using of extended release Gabapentin. Reducing the incidence of chronic post-amputation pain and improving clinical outcomes postoperatively.

Eligible Conditions
  • Pain
  • Quality of Life

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~visit 1, 2, 3, 4, 5, 6
This trial's timeline: 3 weeks for screening, Varies for treatment, and visit 1, 2, 3, 4, 5, 6 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Pain Numeric Rating Scale at rest
Secondary outcome measures
Change in Pain numeric rating scale at movement.
Other outcome measures
Modified brief pain inventory (short form)

Side effects data

From 2021 Phase 4 trial • 88 Patients • NCT03012815
2%
Allergic reaction
100%
80%
60%
40%
20%
0%
Study treatment Arm
Gabapentin
Benzodiazepine

Trial Design

1Treatment groups
Experimental Treatment
Group I: GraliseExperimental Treatment1 Intervention
Efficacy of Gralise

Find a Location

Who is running the clinical trial?

Chicago Anesthesia Pain SpecialistsLead Sponsor
3 Previous Clinical Trials
178 Total Patients Enrolled
Kenneth D Candido, M.D.Principal InvestigatorChicago Anesthesia Pain Specialists
2 Previous Clinical Trials
70 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Once Daily Gabapentin in the Treatment of Post Amputation Pain
Kenneth D Candido 2013. "Once Daily Gabapentin in the Treatment of Post Amputation Pain". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT01776671.
All > Gabapentin
~1 spots leftby May 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top